IP Library Granted Patent US 11,173,321
Granted Patent B2
US 11,173,321 · App. 16/675,862 · Granted Nov 16, 2021

System for its use to treat Leukemia

Inventor: Mohamed A Basiony (Kenmore, WA)
A61N5/0624A61L2/0047A61M1/30A61M1/34A61M1/3681A61N5/0601A61M1/0259A61M2202/0413A61M2202/203A61M2205/053A61N2005/0602A61N2005/0661
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,173,321
App. No.
16/675,862
Granted
Nov 16, 2021
Kind
B2
Abstract

A system to be used to treat Leukemia, comprises a device to power, control and monitor an ultraviolet radiation as well as to monitor a blood contactless conductivity; and a catheter assembly with an inner dialysis catheter, an ultraviolet radiation source and a differential coil sensor. The system is using wavelengths of ultraviolet radiation to destroy infectious microbes that are in the blood and that are inside circulating tumor cells directly and indirectly as well as to destroy infectious microbes at primary tumor location (bone marrow). This is done without withdrawing the blood out of the body. Furthermore, the system measures a blood conductivity to evaluate the treatment process in a real time during the operation.

Claims (8)

1. A process, comprising two phases of operation:

a phase one which is a blood irradiation session wherein, a catheter assembly comprising an inner dialysis catheter body, two end openings at its distal end, two extension tubes with luer connectors at its proximal end, an ultraviolet radiation source, and a differential coil sensor at the distal end is inserted in a vein;

wherein the differential coil sensor comprises one transmitter coil arranged between two receiver coils;

wherein the catheter assembly is connected to a device that powers, controls, and monitors the ultraviolet source and differential coil sensor with a cable;

irradiating blood with ultraviolet radiation via said ultraviolet radiation source to destroy microbes until normal bodily functions are observed while measuring blood conductivity with the differential coil sensor to measure acidic waste created by destroyed microbes using the device;

a second phase which is a hemofiltration session wherein, the catheter assembly is disconnected from the device and is connected to a hemofiltration machine to infuse medication/s and to remove circulating endotoxins from the blood by filtration.

2. The process of claim 1 , wherein irradiating the blood with ultraviolet radiation directly destroys the microbes.

3. The process of claim 2 , wherein irradiating the blood with ultraviolet radiation induces hemoglobin to continuously vibrate and emit secondary ultraviolet radiations that destroy microbes.

Continuity (2)
Provisional Application 62758557 · Nov 10, 2018
Related Publication 20200147409A1 · May 14, 2020